Literature DB >> 12240788

Low serum levels of high-density lipoprotein cholesterol and hypolipidaemic treatment.

Genovefa D Kolovou1, Dennis V Cokkinos.   

Abstract

Low serum levels of high-density lipoprotein (HDL) cholesterol is an independent risk factor for coronary artery disease. Raising HDL cholesterol should be an important therapeutic goal in patients with coronary artery disease. Fibrates can reduce the risk of cardiac events and death from coronary artery disease.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12240788     DOI： 10.1185/030079902125000534

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.580


  6 in total

Review 1.  Pathophysiology of dyslipidaemia in the metabolic syndrome.

Authors:  G D Kolovou; K K Anagnostopoulou; D V Cokkinos
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

2.  Postprandial hypertriglyceridaemia in patients with Tangier disease.

Authors:  G Kolovou; D Daskalova; K Anagnostopoulou; I Hoursalas; V Voudris; D P Mikhailidis; D V Cokkinos
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

3.  The role of common variants of the cholesteryl ester transfer protein gene in left main coronary artery disease.

Authors:  Genovefa Kolovou; Ioannis Vasiliadis; Vana Kolovou; Agathi Karakosta; Sophie Mavrogeni; Evaggelia Papadopoulou; Spiridon Papamentzelopoulos; Vasiliki Giannakopoulou; Apostolia Marvaki; Dimitrios Degiannis; Helen Bilianou
Journal:  Lipids Health Dis       Date:  2011-09-07       Impact factor: 3.876

4.  Cholesteryl ester transfer protein gene and effectiveness of lipid lowering of atorvastatin.

Authors:  Genovefa Kolovou; Constantinos Mihas; Katherine Anagnostopoulou; Vana Kolovou; Vasiliki Giannakopoulou; Peggy Kostakou; Marianna Stamatelatou; Sophie Mavrogeni; Dimitrios Degiannis; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2010-12-10

5.  Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia.

Authors:  Genovefa D Kolovou; Katherine Anagnostopoulou; Nektarios D Pilatis; Klelia D Salpea; Ioannis S Hoursalas; Ilias Petropoulos; Helen I Bilianou; Dennis V Cokkinos
Journal:  Vasc Health Risk Manag       Date:  2005

Review 6.  Lipidomics in vascular health: current perspectives.

Authors:  Genovefa Kolovou; Vana Kolovou; Sophie Mavrogeni
Journal:  Vasc Health Risk Manag       Date:  2015-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.